Artificial intelligence may soon play a critical role in choosing which depression therapy is best for patients.
A national trial initiated by UT Southwestern in 2011 to better understand mood disorders has produced what scientists are calling the project’s flagship finding: a computer that can accurately predict whether an antidepressant will work based on a patient’s brain activity.
The new research is the latest among several studies from the trial that cumulatively show how high-tech strategies can help doctors objectively diagnose and prescribe depression treatments. Although implementing these approaches will take time, researchers predict tools such as AI, brain imaging, and blood tests will revolutionize the field of psychiatry in the coming years.
“These studies have been a bigger success than anyone on our team could have imagined,” says Madhukar Trivedi, M.D., a UT Southwestern psychiatrist who oversaw the multi-site trial involving Stanford, Harvard and other institutions. “We provided abundant data to show we can move past the guessing game of choosing depression treatments and alter the mindset of how the disease should be diagnosed and treated.”
The study published in Nature Biotechnology included more than 300 participants with depression who were randomly chosen to receive either a placebo or an SSRI (selective serotonin reuptake inhibitor), the most common class of antidepressant. Researchers used an electroencephalogram, or EEG, to measure electrical activity in the participants’ cortex before they began treatment. The team then developed a machine-learning algorithm to analyze and use the EEG data to predict which patients would benefit from the medication within two months.
Not only did the AI accurately predict outcomes, further research suggested that patients who were doubtful to respond to an antidepressant were likely to improve with other interventions such as psychotherapy or brain stimulation.
The findings were validated in three additional patient groups.
“This study takes previous research, showing that we can predict who benefits from an antidepressant, and actually brings it to the point of practical utility,” says Amit Etkin, M.D., Ph.D., a Stanford University psychiatry professor who worked with Trivedi to develop the algorithm.
Among the next steps, researchers say, is developing an AI interface that can be widely integrated with EEGs across the country, as well as seeking approval from the U.S. Food and Drug Administration.
Signatures of depression
Data from the study derive from the 16-week EMBARC trial, which Trivedi initiated at four U.S. sites to establish biology-based, objective strategies to remedy mood disorders.
The project evaluated patients with major depressive disorder through brain imaging and various DNA, blood, and other tests. His goal was to address a troubling finding from another study he led (STAR*D) that found up to two-thirds of patients do not adequately respond to their first antidepressant.
“We went into this thinking, ‘Wouldn’t it be better to identify at the beginning of treatment which treatments would be best for which patients?'” Trivedi explains.
Previous EMBARC studies identified various predictive tests, including the use of magnetic resonance imaging (MRI) to examine brain activity in both a resting state and during the processing of emotions. EEG will likely be the most commonly used tool, Trivedi says, because it’s less expensive and – in most cases – will be equally or more effective.
However, a blood test or MRI may be needed for some patients if the depression is manifesting itself in a different way.
“There are many signatures of depression in the body,” Trivedi says. “Having all these tests available will improve the chances of choosing the right treatment the first time.”
According to data from the National Health and Nutrition Examination Survey, antidepressant use in the U.S. has increased nearly 65% over a decade and a half – from 7.7% in 1999-2002 to 12.7% in 2011-2014. Trivedi says the expanded use of medications makes it more critical to further understand the underpinnings of depression and ensure patients are prescribed an effective therapy.
While his team continues to evaluate data from the EMBARC trial, Trivedi has initiated other large research projects to help improve the remission rate of depression. Among them is D2K, a study that will enroll 2,500 patients with depression and bipolar disorders and follow them for 20 years. In addition, RAD is a 10-year study of 2,500 participants (ages 10-24) that will uncover factors for reducing the risk of developing mood or anxiety disorders.
Utilizing some of these enrollees, Trivedi’s research team will study the results from several other tests to assess patients’ biological signatures to determine the most effective treatment.
“It can be devastating for a patient when an antidepressant doesn’t work,” Trivedi says. “Our research is showing that they no longer have to endure the painful process of trial and error.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Houston Roughnecks player tackles depression to make his way back onto the fieldon February 23, 2020 at 5:23 pm
A former NFL player and Super Bowl record holder had to tackle depression in order to get back to football. Houston Roughnecks defensive player, Kony Ealy, enjoys being with his new team. "It feels ...
- ‘Rising signs of depression, in Turkey’ warns medical experton February 23, 2020 at 3:32 pm
According to data from the Health Ministry, increasing number of people in Turkey suffer from depression, said Professor Mansur Beyazyürek. “Independent of their socio-economic level or political ...
- Depression, It’s Not What Everyone Thinks It Ison February 23, 2020 at 11:35 am
Depression is more than just feeling unhappy or sad; it is a constant state of indescribable heaviness that is difficult to quantify. Dysthymia, or a “low-level” state of feeling blue, is different ...
- Melanie C opens about depressionon February 23, 2020 at 11:22 am
Melanie C feels her depression was sparked after a row with her Spice Girls bandmate Victoria Beckham backstage at the BRITs in 1996, as she was so "embarrassed" by what happened.
- Tyson Fury thanks Deontay Wilder for motivating his comeback from depression in 3-year-old videoon February 23, 2020 at 8:54 am
I’m coming back for you baby. I’m coming back for you!” Wilder’s famous smack talk helped Fury get right and start training again. Since then, Fury has been open about his struggles with depression ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Predicting depression patient outcomes
- How Artificial Intelligence Can Help Pick the Best Depression Treatments for Youon February 20, 2020 at 5:18 am
“This EEG lab test is quick”—it takes just a few minutes—”cost-effective, and its outcome ... based on the patient’s EEG patterns “to see if these results hold true.” Etkin believes that in about five ...
- Development of an early-warning system for high-risk patients for suicide attempt using deep learning and electronic health recordson February 20, 2020 at 3:59 am
Mental health disorders including depression, bipolar disorders ... the constructed prediction model was still able to distinguish the patients with high/very high risk of suicide attempts from those ...
- Effort-related behavior may predict relapse risk after antidepressant discontinuationon February 19, 2020 at 12:34 pm
“The decision to expend effort to obtain rewards also appears to be a robust feature of depression; patients with current depression ... the 6 months following discontinuation as the main outcome.
- Brain Scan may predict response of antidepressant in depression patientson February 18, 2020 at 3:28 am
USA: The researchers in a new study, published in the journal Nature Biotechnology, have discovered a neural signature that can predict which depression patients ... in line with the patients' ...
- Brain Scans Could Help Depression Patients Find Right Treatmenton February 12, 2020 at 6:46 pm
The study included more than 300 participants with depression who were randomly chosen ... Not only did the artificial intelligence accurately predict outcomes, further research suggested patients who ...